BD PHOENIX¿ NMIC-311
Report
- Report Number
- 1119779-2025-02557
- Event Type
- Malfunction
- Date Received
- August 7, 2025
- Date of Event
- July 14, 2025
- Report Date
- September 26, 2025
- Manufacturer
- BECTON DICKINSON & CO. (SPARKS)
- Product Code
- LON
- UDI-DI
- 30382904494521
- PMA / PMN Number
- SEE H11
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
B3. DATE OF EVENT IS UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. THERE WERE MULTIPLE 510K NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G4. PMA/510(K)#: K020322, K022129, K023444, K023634, K023858, K024153, K031530, K031699, K031912, K032299, K032567, K032655, K033362, K033458, K033560, K041384, K042932, K052269, K060214, K060217, K060257, K060444, K060447, K061327, K061355, K062207, K062944, K063301, K063486, K063573, K063811, AND K06382. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR FALSE POSITIVE ESBL RESULTS WHEN USING PHOENIX PANEL NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBER 5127465. CUSTOMER RETURNED PANELS, ISOLATES OR PHOENIX GENERATED LAB REPORTS WERE NOT AVAILABLE FOR THE INVESTIGATION. IT IS TO BE NOTED THAT THE NMIC-311 DOES NOT INCLUDE CPO DETECT. TO INVESTIGATE, RETENTION PANELS OF THE COMPLAINT BATCH AND CONTROL PANELS OF THE SAME MATERIAL BUT DIFFERENT BATCH NUMBER WERE INOCULATED WITH IN HOUSE ISOLATE ESCHERICHIA COLI A25922 AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL FLAGS. ALL PANELS RETURNED THE ISOLATE WITH ESBL NEGATIVE RESULTS; THEREFORE, THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORD WAS SATISFACTORY, AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED, AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY. PLEASE CONTINUE TO COMMUNICATE ANY ADDITIONAL CONCERNS.
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 THE USER NOTED THAT THERE WAS AN INCREASE IN EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) AND CARBAPENEM RESISTANT ISOLATES. ADDITIONALLY, THE USER NOTED QC FAILURES ASSOCIATED WITH HIGH MICS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 5 OF 8.
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 THE USER NOTED THAT THERE WAS AN INCREASE IN EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) AND CARBAPENEM RESISTANT ISOLATES. ADDITIONALLY, THE USER NOTED QC FAILURES ASSOCIATED WITH HIGH MICS. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 5 OF 8.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 501219 | BD PHOENIX¿ NMIC-311 | SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION | LON | BECTON DICKINSON & CO. (SPARKS) | 5127465 | 30382904494521 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |